Shares of Transcept Pharmaceuticals (TSPT) soar in premarket trading, up 15.5%, after the firm...


Shares of Transcept Pharmaceuticals (TSPT) soar in premarket trading, up 15.5%, after the firm announces privately-held Purdue exercised its option to commercialize Intermezzo in the U.S. with a Q2 launch planned. Purdue will kick in $100M to support sales and marketing of the sleeping disorder treatment during its first year on the market.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs